The COL1A1 and COL5A1 variants have been associated with the risk of musculoskeletal injuries. Therefore, the main aim of the study was to investigate the association between three polymorphisms within two genes (rs1800012 in COL1A1, as well as rs12722 and rs13946 in COL5A1) and the reported, yet rarely described in the literature, injuries of the joint and muscle area in a physically active Caucasian population. Polish students (n = 114) were recruited and divided into the following two groups: students with (n = 53) and without (n = 61) injures. Genotyping was carried out using real-time PCR. The results obtained revealed a statistically significant association between rs1800012 COL1A1 and injury under an overdominant model. Specifically, when adjusted for age and sex, the GT heterozygotes had a 2.2 times higher chance of being injured compared with both homozygotes (TT and GG, 95% CI 0.59–5.07, p = 0.040). However, no significant interaction between the COL5A1 variants, either individually or in haplotype combination, and susceptibility to injury were found. In addition, the gene–gene interaction analysis did not reveal important relationships with the musculoskeletal injury status. It was demonstrated that rs1800012 COL1A1 may be positively associated with physical activity-related injuries in a Caucasian population. Harboring the specific GT genotype may be linked to a higher risk of being injured.
Effective treatment of central nervous system (CNS) infections remains a major challenge, as most therapeutic agents do not efficiently cross the blood–brain barrier (BBB) and the blood–cerebrospinal fluid barrier (BCSFB). Coumarin derivatives are of particular interest due to their broad pharmacological activity, favorable safety profile, and potential to penetrate biological barriers. Eight novel coumarin-based peptidomimetics functionalized with trifluoromethyl or methyl scaffolds were synthesized and evaluated as antimicrobial agents with the ability to cross the blood–brain barrier. Antimicrobial activity of the investigated compounds was tested against Staphylococcus aureus and multiple Escherichia coli strains (K12, R2, R3, R4) using minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) assays. Cytotoxicity was assessed in vitro in BALB/c-3T3 mouse fibroblasts and αT3-1 pituitary gonadotrope cells using the MTT assay. In vivo studies were performed in sheep to assess transfer of the compounds from blood to cerebrospinal fluid (CSF). All synthesized derivatives demonstrated antimicrobial activity and acceptable cytotoxicity, comparable to those of clinically used antibiotics. CF3-modified coumarin peptidomimetics show promise as antimicrobial agents with the potential to penetrate the BBB/BCSFB. These findings support further investigation of coumarin-based scaffolds as a platform for the development of novel therapeutics for CNS infections.
1 January 2022 in Central European Journal of Sport Sciences and Medicine
Introduction: Improper eating habits in childhood, usually based on a Western diet, can lead to overweight and obesity. They are also an important factor in the increased risk of developing many diet-related diseases later in life. Early identification of school-aged children with poor eating habits can help reduce the risk of obesity and the development of chronic diseases in adulthood. The aim of the present study was to analyze selected dietary habits of school-aged children and adolescents.Material and Methods: The study involved data collected from 2986 children and adolescents aged 10 to 18, attending specific schools in Poland that are part of the e-WF program.Results: In the study group, 76% of children and adolescents reported consuming 3-4 meals per day. A little over 11% restricted themselves to fewer meals, while the remainder adopted a pattern of 5 or more meals. Irregular eating patterns were reported by 40.7% of respondents.Conclusions: In view of the more frequent occurrence of nutritional abnormalities in children and adolescents, and thus the existence of a greater risk for the emergence of numerous consequences in later years of life, it is necessary to systematically monitor diet as a risk factor for the development of overweight and obesity, in order to implement interventions to counteract weight gain at an early stage of adverse changes.
1 January 2026 in Central European Journal of Sport Sciences and Medicine
The contemporary lifestyle of women working in offices leads to limited physical activity and sedentary behavior, which increases the risk of health problems. Digital tools, including training platforms, offer a potentially effective solution for supporting healthy lifestyle changes. The aim of the study was to assess the impact of using a training platform on physical activity levels, selected eating habits, sleep quality, and lifestyle factors among adult women working in offices. The study was longitudinal in nature and included professionally active adult women (n=158) employed in office positions in state-owned entities in the West Pomeranian Voivodeship. Data were collected at four time points: T0 (baseline), T3 (3 months), T6 (6 months), and T9 (9 months). A diagnostic survey approach was employed, utilizing proprietary questionnaires and the Athens Insomnia Scale. Analyses were performed using the Friedman test and post-hoc analyses with Bonferroni correction. During the 9-month intervention, a significant increase in physical activity levels was observed, including an increase in the frequency and duration of activities of varying intensity. Some changes in dietary habits were also observed, including increased fluid and vegetable consumption. No changes in between-meal snacking were observed. Analysis of sleep parameters revealed a significant deterioration in subjective sleep quality throughout the intervention. The training platform proved to be an effective tool for supporting increased physical activity in working women, but its impact on other lifestyle factors, particularly sleep quality, was limited.
Introduction: Acute caffeine may modify laboratory-evoked pain, but its relevance to clinical analgesia is uncertain. We systematically reviewed controlled experiments of caffeine administered alone in healthy humans, distinguishing pain intensity, threshold, tolerance, and induced hypoalgesia. Methods: Six databases were searched through 1 September 2026 using PRISMA 2020 methods. Nine experiments (216 analyzed participants) were included; five (130 participants) supplied pain-intensity contrasts for an exploratory REML random-effects meta-analysis with Hartung–Knapp confidence intervals. Results: The pooled effect was uncertain (Hedges’ g = 0.61, 95% CI −0.33 to 1.54; p = 0.146; I2 = 89.0%). Exclusion of the influential graph-derived cold-immersion estimate reduced g to 0.16 (95% CI −0.22 to 0.53; I2 = 24.7%). Pain threshold, tolerance, and induced hypoalgesia were not combined with pain intensity. Protocol differences could be described but not tested as reliable moderators. Adverse-event ascertainment varied substantially. Conclusions: The available evidence does not establish a consistent generalized hypoalgesic effect of caffeine alone. It can inform standardization of experimental pain research, but cannot justify caffeine treatment for clinical pain.